{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:40:04Z","timestamp":1792431604912,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-026-01200-7","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:18:05Z","timestamp":1784740685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico prioritization of potential matrix metalloproteinase-13 inhibitors for cartilage degeneration in knee injury-associated osteoarthritis"],"prefix":"10.1186","volume":"26","author":[{"given":"Aijuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"3","key":"1200_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1249\/MSS.0b013e318277acca","volume":"45","author":"DM Swenson","year":"2013","unstructured":"Swenson DM, Collins CL, Best TM, Flanigan DC, Fields SK, Comstock RD. Epidemiology of knee injuries among U.S. High school athletes, 2005\/2006\u20132010\/2011. Med Sci Sports Exercise. 2013, Mar;45(3):462\u201369. https:\/\/doi.org\/10.1249\/MSS.0b013e318277acca.","journal-title":"Med Sci Sports Exercise"},{"issue":"9","key":"1200_CR2","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/medicina61091672","volume":"61","author":"GA Tolan","year":"2025","unstructured":"Tolan GA, Raducan ID, Uivaraseanu B, Tit DM, Bungau GS, Radu A-F, et al. Nationwide epidemiology of hospitalized acute ACL ruptures in Romania: a 7-year analysis (2017\u20132023). Medicina (Kaunas). 2025, Sep;61(9):1672. https:\/\/doi.org\/10.3390\/medicina61091672.","journal-title":"Medicina (Kaunas)"},{"key":"1200_CR3","doi-asserted-by":"publisher","first-page":"113666","DOI":"10.1016\/j.ejmech.2021.113666","volume":"224","author":"AM Bendele","year":"2021","unstructured":"Bendele AM, Neelagiri M, Neelagiri V, Sucholeiki I. Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of osteoarthritis. Eur J Med Chem. 2021, Nov;224:113666. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113666.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"1200_CR4","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s10067-025-07347-6","volume":"44","author":"JL Ren","year":"2025","unstructured":"Ren JL, Yang J, Hu W. The global burden of osteoarthritis knee: a secondary data analysis of a population-based study. Clin Rheumatol. 2025;44(4):1769\u2013810. https:\/\/doi.org\/10.1007\/s10067-025-07347-6.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1200_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/reum\/168503","volume":"61","author":"\u0141 Pulik","year":"2023","unstructured":"Pulik \u0141, \u0141\u0119gosz P, Motyl G. Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: a state of the art review. Reumatologia. 2023;61(3):191\u2013201. https:\/\/doi.org\/10.5114\/reum\/168503.","journal-title":"Reumatologia"},{"issue":"1","key":"1200_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejr.2022.09.002","volume":"45","author":"AM Elamir","year":"2023","unstructured":"Elamir AM, Zahra A, Senara SH, Ezzat EM, El Sayed HS. Diagnostic value of matrix metalloproteinases-1, \u22123 and \u221213 in patients with primary knee osteoarthritis: relation to radiological severity. Egypt Rheumatol. 2023, Jan;45(1):17\u201320. https:\/\/doi.org\/10.1016\/j.ejr.2022.09.002.","journal-title":"Egypt Rheumatol"},{"key":"1200_CR7","doi-asserted-by":"publisher","first-page":"147120","DOI":"10.1016\/j.ijbiomac.2025.147120","volume":"326","author":"R Mazloomnejad","year":"2025","unstructured":"Mazloomnejad R, Ahmadi A, Shirzad F, Yaghoobi A, Tayebi T, Taheri AT, et al. Matrix metalloproteinase inhibitor-loaded extracellular matrix macromolecules enhance cartilage regeneration and inhibit degeneration in osteoarthritis. Int J Biol Macromolecules. 2025, Sep;326:147120. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147120.","journal-title":"Int J Biol Macromolecules"},{"key":"1200_CR8","doi-asserted-by":"publisher","first-page":"1285455","DOI":"10.3389\/fphar.2023.1285455","volume":"14","author":"Y Bian","year":"2023","unstructured":"Bian Y, Xiang Z, Wang Y, Ren Q, Chen G, Xiang B, et al. Immunomodulatory roles of metalloproteinases in rheumatoid arthritis. Front Pharmacol. 2023, Nov;14:1285455. https:\/\/doi.org\/10.3389\/fphar.2023.1285455.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1200_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/jcm14041263","volume":"14","author":"K Baran","year":"2025","unstructured":"Baran K, Czechowska A, Kopacz K, Padula G, Migdalska-S\u0119k M, Tomaszewski W, et al. MMP13 mRNA expression level as a potential marker for knee OA progression\u2014an observational study. J Clin Med. 2025;14(4):1263. https:\/\/doi.org\/10.3390\/jcm14041263.","journal-title":"JCM"},{"key":"1200_CR10","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.bbiosy.2024.100090","volume":"13","author":"A Mukherjee","year":"2024","unstructured":"Mukherjee A, Das B. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis. Biomater Biosyst. 2024, Feb;13:100090. https:\/\/doi.org\/10.1016\/j.bbiosy.2024.100090.","journal-title":"Biomater Biosyst"},{"issue":"22","key":"1200_CR11","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.2174\/0929867326666181217153118","volume":"27","author":"Y Wan","year":"2020","unstructured":"Wan Y, Li W, Liao Z, Yan M, Chen X, Tang Z. Selective MMP-13 inhibitors: promising agents for the therapy of osteoarthritis. Curr Med Chem. 2020;27(22):3753\u201369. https:\/\/doi.org\/10.2174\/0929867326666181217153118.","journal-title":"CMC"},{"key":"1200_CR12","unstructured":"Considerations in modern regenerative medicine for osteoarthritis [Internet]. [cited 2025 Nov 28]. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12139601\/."},{"key":"1200_CR13","unstructured":"Recent advances in the management of knee osteoarthritis: a narrative review [Internet]. [cited 2025 Nov 28]. https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2025.1523027\/full."},{"issue":"11","key":"1200_CR14","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.joca.2025.08.015","volume":"33","author":"A Dell\u2019isola","year":"2025","unstructured":"Dell\u2019isola A, Recenti F, Giardulli B, Lawford BJ, Kiadaliri A. Osteoarthritis year in review 2025: epidemiology and therapy. Osteoarthr Cartil. 2025, Nov;33(11):1300\u201306. https:\/\/doi.org\/10.1016\/j.joca.2025.08.015.","journal-title":"Osteoarthr Cartil"},{"key":"1200_CR15","doi-asserted-by":"crossref","unstructured":"Langworthy M, Dasa V, Spitzer AI. Knee osteoarthritis: disease burden, available treatments, and emerging options [Internet]. [2025 Nov 28]: https:\/\/journals.sagepub.com\/doi\/10.1177\/1759720X241273009.","DOI":"10.1177\/1759720X241273009"},{"issue":"6","key":"1200_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1530\/EOR-2025-0050","volume":"10","author":"G Im","year":"2025","unstructured":"Im G. Considerations in modern regenerative medicine for osteoarthritis. EFORT Open Rev. 2025, Jun;10(6):336\u201344. https:\/\/doi.org\/10.1530\/EOR-2025-0050.","journal-title":"EFORT Open Rev"},{"issue":"6","key":"1200_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12272-025-01551-3","volume":"48","author":"Z Jenei-Lanzl","year":"2025","unstructured":"Jenei-Lanzl Z, Maurer S, Brenner RE, Zaucke F, Fuchs M, Riegger J. Emerging concepts and challenges in the development of disease-modifying osteoarthritis drugs \u2013 a more refined perspective. Arch Pharm Res. 2025;48(6):467\u201394. https:\/\/doi.org\/10.1007\/s12272-025-01551-3.","journal-title":"Arch Pharm Res"},{"key":"1200_CR18","unstructured":"Emerging concepts and challenges in the development of disease-modifying osteoarthritis drugs: a more refined perspective [Internet]. [cited 2025 Nov 28].https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12241195\/."},{"issue":"22","key":"1200_CR19","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1039\/d3tb02871b","volume":"12","author":"HS Roy","year":"2024","unstructured":"Roy HS, Murugesan P, Kulkarni C, Arora M, Nagar GK, Guha R, et al. On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis. J Mater Chem B. 2024, Jun;12(22):5325\u201338. https:\/\/doi.org\/10.1039\/d3tb02871b.","journal-title":"J Mater Chem B"},{"key":"1200_CR20","doi-asserted-by":"publisher","unstructured":"Bateman A, Martin M-J, Orchard S, Magrane M, Adesina A, Ahmad S, et al. UniProt: the universal protein Knowledgebase in 2025. Nucleic Acids Res. 2025 Jan; 53(D1). doi: 53(D1):D609\u201317. https:\/\/doi.org\/10.1093\/nar\/gkae1010.","DOI":"10.1093\/nar\/gkae1010"},{"key":"1200_CR21","unstructured":"U. UniProtKB: P45452 MMP13_HUMAN [Internet]. [cited 2025 Nov 28]. https:\/\/www.uniprot.org\/uniprotkb\/P45452\/entry."},{"key":"1200_CR22","unstructured":"Computational approaches and drug discovery: where are we going? [Internet]. [cited 2025 Nov 28].https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10935270\/."},{"key":"1200_CR23","unstructured":"Current status of computational approaches for small molecule drug discovery. J Med Chem [Internet]. [cited 2025 Nov 28]. https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.4c02462."},{"key":"1200_CR24","unstructured":"Molecular docking study of flavonoid compounds for possible therapeutic application [Internet]. [cited 2025 Nov 28]. https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2020-0036\/html."},{"key":"1200_CR25","doi-asserted-by":"publisher","unstructured":"Gangadhara V, Abraham A. Optimizing 3D structural predictions of murine \u03b22-adrenergic receptor: swiss-model outperforms AlphaFolds. Ind. J. Pharm. Edu. Res. 2025, Apr;59(2s):s641\u201355. https:\/\/doi.org\/10.5530\/ijper.20256524.","DOI":"10.5530\/ijper.20256524"},{"key":"1200_CR26","unstructured":"Expasy. ProtParam [Internet]. [cited 2025 Nov 28]. https:\/\/web.expasy.org\/protparam\/."},{"key":"1200_CR27","unstructured":"NPS@. SOPMA secondary structure prediction [Internet]. [cited 2025 Nov 28]. https:\/\/npsa.lyon.inserm.fr\/cgi-bin\/npsa_automat.pl?page=\/NPSA\/npsa_sopma.html."},{"key":"1200_CR28","unstructured":"PSIPRED Workbench [Internet]. [cited 2025 Nov 28]. https:\/\/bioinf.cs.ucl.ac.uk\/psipred\/."},{"key":"1200_CR29","unstructured":"UCLA-DOE Institute. ERRAT [Internet]. [cited 2025 Nov 28]. https:\/\/www.doe-mbi.ucla.edu\/errat\/."},{"key":"1200_CR30","unstructured":"Deciphering pH-driven dynamics of prolyl endopeptidases: unveiling structural insight in celiac disease using computational techniques [Internet]. [cited 2025 Nov 28]. https:\/\/www.researchsquare.com\/article\/rs-5708047\/v1."},{"key":"1200_CR31","doi-asserted-by":"crossref","unstructured":"P. 4: a modular web server for protein-ligand binding site prediction and downstream analysis. Nucleic acids res [Internet]. [cited 2025 Nov 28]. https:\/\/academic.oup.com\/nar\/article\/53\/W1\/W466\/8136464.","DOI":"10.1093\/nar\/gkaf421"},{"key":"1200_CR32","unstructured":"PrankWeb [Internet]. [cited 2025 Nov 28]. https:\/\/prankweb.cz\/."},{"key":"1200_CR33","doi-asserted-by":"publisher","first-page":"130009","DOI":"10.1016\/j.bmcl.2024.130009","volume":"114","author":"Y Wang","year":"2024","unstructured":"Wang Y. Novel drug discovery approaches for MMP-13 inhibitors in the treatment of osteoarthritis. Bioorg Med Chem Lett. 2024, Dec;114:130009. https:\/\/doi.org\/10.1016\/j.bmcl.2024.130009.","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"1200_CR34","first-page":"1223","volume":"95","author":"F Mo","year":"2025","unstructured":"Mo F, et al. MMP-13 at the crossroads of inflammation and catabolism: unraveling signaling cascades in knee osteoarthritis. Hum Biol. 2025, Sep;95(4):1223\u201329.","journal-title":"Hum Biol"},{"key":"1200_CR35","unstructured":"The role of collagen and collagen I\/III ratio in pathological conditions: insights into molecular mechanisms and therapeutic approaches [Internet]. [cited 2025 Nov 28]. https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2025.1679625\/full."},{"issue":"4","key":"1200_CR36","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/ijms22041742","volume":"22","author":"Q Hu","year":"2021","unstructured":"Hu Q, Ecker M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. IJMS. 2021, Feb;22(4):1742. https:\/\/doi.org\/10.3390\/ijms22041742.","journal-title":"IJMS"},{"key":"1200_CR37","doi-asserted-by":"crossref","unstructured":"Matrix metalloproteinases in inflammatory dermatoses [Internet]. [cited 2025 Nov 28]. https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10319.","DOI":"10.3390\/ijms262110319"},{"key":"1200_CR38","unstructured":"Recent advances in the design and development of small-molecule MMP-2 inhibitors. Future Med Chem [Internet]. [cited 2025 Nov 28]. https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/17568919.2025.2570970."},{"key":"1200_CR39","unstructured":"Computational design of MMP-13 inhibitors using a combined approach of machine learning, docking, and molecular dynamics. Mol Divers [Internet]. [cited 2025 Nov 28]. https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11358-5."},{"key":"1200_CR40","unstructured":"Matrix metalloproteinase inhibitor-loaded extracellular matrix macromolecules enhance cartilage regeneration and inhibit degeneration in osteoarthritis [Internet]. [cited 2025 Nov 28]. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0141813025076779."},{"key":"1200_CR41","doi-asserted-by":"publisher","first-page":"750047","DOI":"10.3389\/fsurg.2021.750047","volume":"8","author":"X Xin","year":"2021","unstructured":"Xin X, Tan Q, Li F, Chen Z, Zhang K, Li F, et al. Potential value of matrix metalloproteinase-13 as a biomarker for osteoarthritis. Front Surg. 2021, Oct;8:750047. https:\/\/doi.org\/10.3389\/fsurg.2021.750047.","journal-title":"Front Surg"},{"key":"1200_CR42","doi-asserted-by":"publisher","unstructured":"Izukashi K, Okumo T, Tatsuo T, Kachi I, Iida Y, Nishio T, et al. Early intervention with boiogito to suppress knee osteoarthritis progression: an experimental approach using a medial meniscus instability rat model. Cureus. 2025, Jan, 17. https:\/\/doi.org\/10.7759\/cureus.77311.","DOI":"10.7759\/cureus.77311"},{"key":"1200_CR43","unstructured":"Kaspiris A, Savvidou O, Nikolaou VS, Koulouvaris P. Novel selective MMP-13 inhibitors are associated with reduced joint damage and increased cartilage regeneration during osteoarthritis progression. Acta Orthop Traumatol Hell. 2025, Jul;76(2). Available from: https:\/\/eexot-journal.com\/aoet\/article\/view\/515."},{"key":"1200_CR44","unstructured":"Computational design of MMP-13 inhibitors using a combined approach of machine learning, docking, and molecular dynamics [Internet]. [cited 2025 Nov 28]. https:\/\/pubmed.ncbi.nlm.nih.gov\/41037200\/."},{"issue":"7","key":"1200_CR45","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.3390\/ijms23073903","volume":"23","author":"E Olivotto","year":"2022","unstructured":"Olivotto E, Belluzzi E, Pozzuoli A, Cigolotti A, Scioni M, Goldring SR, et al. Do synovial inflammation and meniscal degeneration impact clinical outcomes of patients undergoing arthroscopic partial meniscectomy? A histological study. Int J Mol Sci. 2022, Mar;23(7):3903. https:\/\/doi.org\/10.3390\/ijms23073903.","journal-title":"IJMS"},{"key":"1200_CR46","unstructured":"Redefining a new frontier in alkaptonuria therapy with AI [Internet]. [cited 2025 Nov 28]. https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/znc-2024-0075\/html."},{"issue":"3","key":"1200_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.71336\/jabs.1477","volume":"19","author":"N Hanif","year":"2025","unstructured":"Hanif N, Amna Arif AA, Sadia Ali SA, Muqaddas Anees MA, Mavra Anees MA, Arshad A, et al. Computational drug design targeting MYH7 for hypertrophic cardiomyopathy integrating molecular docking, density functional theory, and molecular dynamics simulations. J Appl Biol Sci. 2025, Sep;19(3):179\u201392. https:\/\/doi.org\/10.71336\/jabs.1477.","journal-title":"J Appl Biol Sci"},{"key":"1200_CR48","unstructured":"PubChem [Internet]. Bethesda (MD): National Library of Medicine. [cited 2025 Nov 28]. https:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"1200_CR49","unstructured":"Long Y, Portelli S, Pires DEV, Ascher DB. toxCSM [Internet]. [cited 2025 Nov 28]. https:\/\/biosig.lab.uq.edu.au\/."},{"issue":"5","key":"1200_CR50","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.31925\/farmacia.2025.5.17","volume":"73","author":"I C\u0103luian","year":"2025","unstructured":"C\u0103luian I. Design and in silico evaluation of novel tacrine-ferulic acid derivatives. 2025. FARMACIA. 2025;73(5):1246\u201355. https:\/\/doi.org\/10.31925\/farmacia.2025.5.17.","journal-title":"FARMACIA"},{"key":"1200_CR51","unstructured":"SwissADME [Internet]. [cited 2025 Nov 28]. https:\/\/www.swissadme.ch\/."},{"issue":"2","key":"1200_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.5281\/zenodo.15741944","volume":"10","author":"Yusuf Sert","year":"2025","unstructured":"Sert Y. Pharmacokinetic evaluation of sulfadicramide through SwissADME: a computational insight into drug-likeness and bioavailability. MAS J Appl Sci. 2025, Jun;10(2):357\u201362. https:\/\/doi.org\/10.5281\/zenodo.15741944.","journal-title":"MAS J Appl Sci"},{"key":"1200_CR53","doi-asserted-by":"publisher","unstructured":"Tejera-Nevado P, Junod N, Kwon EH, Prieto-Santamar\u00eda L, Rodr\u00edguez-Gonz\u00e1lez A. Benchmarking docking tools on experimental and artificial intelligence-predicted protein structures. 2025 IEEE 38th International Symposium on Computer-Based Medical Systems (CBMS). 2025 Jun; p. 252\u201357. doi: https:\/\/doi.org\/10.1109\/CBMS65348.2025.00058.","DOI":"10.1109\/CBMS65348.2025.00058"},{"key":"1200_CR54","doi-asserted-by":"publisher","first-page":"100406","DOI":"10.1016\/j.medntd.2025.100406","volume":"28","author":"S Murugan","year":"2025","unstructured":"Murugan S, Moulishankar A, Palanivel S, Muthu Kumaradoss K, Thirugnanasambandam S. Computational drug discovery of nitroimidazole compounds targeting ddn protein of mycobacterium tuberculosis: insights from QSAR modeling, ADMET, molecular docking, and molecular dynamics simulation studies. Med Novel Technol Devices. 2025, Dec;28:100406. https:\/\/doi.org\/10.1016\/j.medntd.2025.100406.","journal-title":"Med Novel Technol Devices"},{"key":"1200_CR55","unstructured":"S. Functional protein association networks [Internet]. [cited 2025 Nov 28]. https:\/\/string-db.org\/."},{"key":"1200_CR56","unstructured":"Drug-minded protein interaction database (DrumPID) for efficient target analysis and drug development. Database [Internet]. [cited 2025 Nov 28]. https:\/\/academic.oup.com\/database\/article\/doi\/10.1093\/database\/baw041\/2630317."},{"key":"1200_CR57","doi-asserted-by":"publisher","unstructured":"Kumar R, Khan SK, Yadav AK, Reetu, R. Integrating computational and experimental approaches in 21st century drug design. JDDHS. 2025, Jul;2(2):83\u201390. https:\/\/doi.org\/10.21590\/jddhs.02.02.04.","DOI":"10.21590\/jddhs.02.02.04"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01200-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:02:09Z","timestamp":1792429329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01200-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01200-7","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No human participants or animals were involved in this study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"121"}}